How is ceftobiprole used in Canada: the CLEAR study final results.

George G ZhanelJustin KosarMelanie BaxterRita DhamiSergio BorgiaNeal IrfanGordon DowMaxime DubeTeagen Rolf von den BaumenCarlo TasciniAnna LeeZain ChaglaGabriel GirouardSamuel Bourassa-BlanchetteMay WuYoav KeynanAndrew WalktyJames A Karlowsky

Published in: Expert review of anti-infective therapy (2024)

In Canada, ceftobiprole is used mostly as directed therapy to treat a variety of severe infections caused by MRSA, in patients failing previous antimicrobials. It is frequently added to, and thus used in combination with daptomycin and/or vancomycin with high microbiological/clinical cure rates, and an excellent safety profile.

Keyphrases

methicillin resistant staphylococcus aureus
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
early onset
patient reported outcomes
smoking cessation